Sabra Healthcare REIT’s (SBRA) “Hold” Rating Reiterated at JMP Securities
Sabra Healthcare REIT Inc. (NASDAQ:SBRA)‘s stock had its “hold” rating reissued by investment analysts at JMP Securities in a research report issued to clients and investors on Friday.
SBRA has been the topic of a number of other reports. Cantor Fitzgerald reiterated a “buy” rating on shares of Sabra Healthcare REIT in a report on Friday, August 19th. Canaccord Genuity reiterated a “hold” rating and issued a $23.00 target price on shares of Sabra Healthcare REIT in a report on Tuesday, May 31st. Zacks Investment Research cut Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a report on Friday, July 22nd. SunTrust Banks Inc. upgraded Sabra Healthcare REIT from a “neutral” rating to a “buy” rating and set a $25.00 target price on the stock in a report on Wednesday, June 1st. Finally, Mizuho cut Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and cut their target price for the stock from $25.00 to $20.00 in a report on Thursday, May 19th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $23.18.
Shares of Sabra Healthcare REIT (NASDAQ:SBRA) traded down 4.49% on Friday, reaching $25.12. 113,006 shares of the company were exchanged. The company has a market cap of $1.64 billion, a price-to-earnings ratio of 30.01 and a beta of 1.20. Sabra Healthcare REIT has a 12 month low of $14.92 and a 12 month high of $26.01. The company’s 50-day moving average price is $24.57 and its 200 day moving average price is $21.62.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/09/sabra-healthcare-reits-sbra-hold-rating-reiterated-at-jmp-securities.html
Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, August 1st. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.58 by $0.03. The firm earned $74.20 million during the quarter, compared to the consensus estimate of $56.04 million. Sabra Healthcare REIT’s revenue for the quarter was up 31.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.53 earnings per share. On average, equities research analysts expect that Sabra Healthcare REIT will post $2.29 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 31st. Investors of record on Monday, August 15th were issued a $0.42 dividend. This represents a $1.68 annualized dividend and a yield of 6.39%. The ex-dividend date of this dividend was Thursday, August 11th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 202.41%.
A number of large investors have recently made changes to their positions in the company. Ladenburg Thalmann Financial Services Inc. raised its stake in shares of Sabra Healthcare REIT by 1.0% in the first quarter. Ladenburg Thalmann Financial Services Inc. now owns 5,194 shares of the company’s stock valued at $104,000 after buying an additional 53 shares during the period. Barclays PLC raised its stake in shares of Sabra Healthcare REIT by 64.6% in the first quarter. Barclays PLC now owns 10,485 shares of the company’s stock valued at $209,000 after buying an additional 4,116 shares during the period. Creative Planning raised its position in Sabra Healthcare REIT by 4.0% in the second quarter. Creative Planning now owns 10,400 shares of the company’s stock worth $215,000 after buying an additional 400 shares during the last quarter. Squarepoint Ops LLC bought a new position in Sabra Healthcare REIT during the first quarter worth $265,000. Finally, Fox Run Management L.L.C. bought a new position in Sabra Healthcare REIT during the second quarter worth $347,000. 92.52% of the stock is owned by institutional investors.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company owns and invests in real estate serving the healthcare industry. The Company’s segment is investments in healthcare-related real estate properties. Its primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.